MX2008010934A - Sistema terapeutico transdermico que contiene escopolamina. - Google Patents

Sistema terapeutico transdermico que contiene escopolamina.

Info

Publication number
MX2008010934A
MX2008010934A MX2008010934A MX2008010934A MX2008010934A MX 2008010934 A MX2008010934 A MX 2008010934A MX 2008010934 A MX2008010934 A MX 2008010934A MX 2008010934 A MX2008010934 A MX 2008010934A MX 2008010934 A MX2008010934 A MX 2008010934A
Authority
MX
Mexico
Prior art keywords
polymer matrix
scopolamine
polymer
flexible
weight
Prior art date
Application number
MX2008010934A
Other languages
English (en)
Inventor
David P Kanios
Juan A Mantelle
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of MX2008010934A publication Critical patent/MX2008010934A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Se describen sistemas flexibles finitos para la administración transdérmica de escopolamina que consiste de: (a) una matriz polimérica que contiene una mezcla de polímeros que contiene (i) un polímero no funcional a base de acrílico que constituye cuando menos aproximadamente 60% en peso del peso seco de la matriz polimérica, y (ii) un polímero de silicona protegido resistente a la amina que constituye no más de aproximadamente 30% en peso seco del peso seco de la matriz polimérica y (b) escopolamina solubilizada en la matriz polimérica en donde el sistema finito flexible está sustancialmente libre de acetato de vinilo y componentes molares. En algunas modalidades, la matriz polimérica también comprende un promotor no polar de la penetración. También se describen métodos para producir y usar esos sistemas finitos flexibles.
MX2008010934A 2006-02-27 2007-02-26 Sistema terapeutico transdermico que contiene escopolamina. MX2008010934A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77725706P 2006-02-27 2006-02-27
PCT/US2007/004911 WO2007100757A2 (en) 2006-02-27 2007-02-26 Transdermal therapeutic system comprising scopolamine

Publications (1)

Publication Number Publication Date
MX2008010934A true MX2008010934A (es) 2008-10-30

Family

ID=38266708

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008010934A MX2008010934A (es) 2006-02-27 2007-02-26 Sistema terapeutico transdermico que contiene escopolamina.

Country Status (11)

Country Link
US (1) US8715723B2 (es)
EP (1) EP1998756A2 (es)
JP (1) JP2009528357A (es)
CN (1) CN101431988A (es)
AU (1) AU2007221117A1 (es)
CA (1) CA2643037C (es)
MX (1) MX2008010934A (es)
NO (1) NO20084088L (es)
RU (1) RU2008138595A (es)
WO (1) WO2007100757A2 (es)
ZA (1) ZA200807408B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758619B2 (en) * 2010-11-15 2020-09-01 The Ohio State University Controlled release mucoadhesive systems
US9717697B2 (en) 2012-10-15 2017-08-01 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
AR094289A1 (es) 2012-12-28 2015-07-22 Noven Pharma Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
CA2896347A1 (en) 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc. Multi-polymer compositions for transdermal drug delivery
WO2014159582A1 (en) 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
CA2956596A1 (en) * 2014-07-31 2016-02-04 Noven Pharmaceuticals, Inc. Silicone-containing acrylic polymers for transdermal drug delivery compositions
JP6807848B2 (ja) 2015-02-06 2021-01-06 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮薬物送達のための感圧粘着剤
US10406116B2 (en) 2015-02-06 2019-09-10 Noven Pharmaceuticals, Inc. Pressure-sensitive adhesives for transdermal drug delivery
EP3506889A1 (en) * 2016-08-03 2019-07-10 Noven Pharmaceuticals, INC. Pressure-sensitive adhesives for transdermal drug delivery
CN110809466A (zh) * 2017-06-26 2020-02-18 罗曼治疗系统股份公司 含东莨菪碱和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
DE102018118507A1 (de) * 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran
US20220160697A1 (en) * 2019-03-19 2022-05-26 Nobelpharma Co., Ltd. Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1991014463A1 (en) 1990-03-28 1991-10-03 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4814168A (en) 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
US5714162A (en) 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19738643C2 (de) 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
WO2000074661A2 (en) 1999-06-05 2000-12-14 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
ES2410532T3 (es) 2000-09-19 2013-07-02 Henkel Ag & Co. Kgaa Adhesivo de acrilo útil en sistemas de administración transdérmica de fármacos
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
JP4704764B2 (ja) * 2005-02-03 2011-06-22 日東電工株式会社 爪貼付用粘着組成物および爪用貼付剤

Also Published As

Publication number Publication date
ZA200807408B (en) 2009-09-30
JP2009528357A (ja) 2009-08-06
US8715723B2 (en) 2014-05-06
NO20084088L (no) 2008-11-19
CA2643037A1 (en) 2007-09-07
CA2643037C (en) 2014-08-05
EP1998756A2 (en) 2008-12-10
WO2007100757A3 (en) 2007-10-18
WO2007100757A2 (en) 2007-09-07
CN101431988A (zh) 2009-05-13
RU2008138595A (ru) 2010-04-10
AU2007221117A1 (en) 2007-09-07
US20070212410A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
MX2008010934A (es) Sistema terapeutico transdermico que contiene escopolamina.
AU2003300835A1 (en) Angle indexer for medical devices
TW200735771A (en) Pesticide delivery system
MY161465A (en) Seed treatment formulations and methods of use
ES2167116T3 (es) Sistema terapeutico transdermico (tts) que contiene pergolida.
DK1061900T3 (da) Dermale præparater
AR097045A2 (es) Sistema terapéutico transdérmico
NZ588883A (en) Permeant delivery system and methods for use thereof
MX339797B (es) Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
WO2007150018A3 (en) Steroid-containing sustained release intraocular implants and related methods
MY161146A (en) Highly-reliable ingestible event markers and methods for using the same
BRPI0518281A2 (pt) inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos
NZ589542A (en) Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone
WO2007092624A3 (en) Peripheral systems
WO2007140180A3 (en) In vivo-customizable implant
NO20084614L (no) Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter
TNSN08365A1 (en) Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer
NO20052894L (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
TW200616589A (en) Transdermal delivery of drugs based on crystal size
WO2009151708A3 (en) Peptide analogs of alpha-melanocyte stimulating hormone
RS52914B (en) AMORPHIC SOLID DISPERSION OF 7-CHLOR-N, N, 5-TRIMETHYL-4-OXO-3-PHENYL-3,5, -Dihydro-4H-pyridazino (4,5-B) INDOL-1-ACETAMIDE
ATE249818T1 (de) Wirkstoffhaltige laminate fur transdermalsysteme
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
NO20062234L (no) Transdemisk,farmasoytisk spray-formulering omfattende en VP/UA kopolymer og en ikke-vandig vehikkel
AU4764800A (en) Transdermal device for the application of testosterone or one of the derivativesthereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal